CIREVETMAB
UNII 44Y3PDN3XY

Substance Identification & Data

This profile provides standardized clinical and technical data for Cirevetmab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 44Y3PDN3XY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2473240-98-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
44Y3PDN3XY
CAS Registry Number
2473240-98-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CIREVETMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188512
National Cancer Institute reference terminology for clinical and research data.
INN ID
11970
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cirevetmab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CIREVETMAB

Common Names & Synonyms

CIREVETMAB [INN]
IMMUNOGLOBULIN G2 (237-ALANINE,238-ALANINE,240-ALANINE), ANTI-(CANIS FAMILIARIS TRANSFORMING GROWTH FACTOR .BETA.1) (CANIS FAMILIARIS-MUS MUSCULUS MONOCLONAL ZTS-00521426 .GAMMA.2-CHAIN), DISULFIDE WITH CANIS FAMILIARIS-MUS MUSCULUS MONOCLONAL ZTS-00521426 .KAPPA.-CHAIN, DIMER

Technical Codes

ZTS-00521426

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus